The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA Peptide Reclassification 2026: What It Means for Providers The Emerging Risk of Peptides in Supplements LegitScript BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with